Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Quality Index
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow quality index. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Quality Index of -1.00x as of December 2024. Operating cash flow of CN¥-60.52 Million is below net income of CN¥60.45 Million, suggesting accrual-heavy earnings not yet converted to cash. See 301281 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Cash flow quality index of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024. Historical Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Shandong Keyuan Pharmaceutical Co. Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Quality Index by Year (2021–2024)
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow quality index by year from 2021 to 2024. Year-by-year earnings quality comparison for Shandong Keyuan Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see Shandong Keyuan Pharmaceutical Co. Ltd. operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.00x | CN¥-60.52 Million | CN¥60.45 Million | ▼ -308.3% |
| 2023 | 0.48x | CN¥37.03 Million | CN¥77.04 Million | ▼ -62.1% |
| 2022 | 1.27x | CN¥115.86 Million | CN¥91.28 Million | ▲ +90.7% |
| 2021 | 0.67x | CN¥52.02 Million | CN¥78.17 Million | — |